CUV 0.64% $13.87 clinuvel pharmaceuticals limited

Ann: SCENESSE European Orphan Drug Designation for VP, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 636 Posts.
    lightbulb Created with Sketch. 303
    It is however enlightening to see how much progress Clinuvel have made in VP in the 8 years since fda odd. None. Almost 5 years since fda epp approval. 200 million in the bank and no progress at all. Waiting for the right time I expect.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.